Search Results - "Manago, Jacqueline"

Incorporation of posttransplant cyclophosphamide as part of standard immunoprophylaxis for all allogeneic transplants: a retrospective, single institution study by Cooper, Dennis L., Manago, Jacqueline, Patel, Vimal, Schaar, Dale, Krimmel, Tracy, McGrath, Mary Kate, Tyno, Anne, Lin, Yong, Strair, Roger

“…The addition of posttransplant cyclophosphamide (PTCy) to standard graft-versus-host disease (GVHD) prophylaxis following haploidentical blood stem transplants…”
Get full text

Implementation of a lisocabtagene maraleucel chimeric antigen receptor T-cell therapy outpatient monitoring program: Multicenter nursing/advanced practice provider perspectives by McEntee, Nicole, Manago, Jacqueline, Lu, ChiaChun, Holmes, Lucy

“…Lisocabtagene maraleucel (liso-cel; Breyanzi), an autologous chimeric antigen receptor T-cell therapy, has demonstrated efficacy and safety in…”
Get full text

Antineoplastic Effects of Partially HLA-Matched Irradiated Blood Mononuclear Cells in Patients With Renal Cell Carcinoma by STRAIR, Roger K, SCHAAR, Dale, BAKER, Christina, DUDEK, Liesel, CIARDELLA, Marie, KURIYAN, Mercy, RUBIN, Arnold, LATTIME, Edmund C, MEDINA, Daniel, TODD, Mary B, AISNER, Joseph, DIPAOLA, Robert S, MANAGO, Jacqueline, KNOX, Beth, JENKINSON, Amanda, SENZON, Rachelle

“…Vaccines, cytokines, and other biologic-based therapies are being developed as antineoplastic agents. Many of these agents are designed to induce an autologous…”
Get full text

Transitioning to a New Lab for HLA Testing: Impact on Workflow and Time to Donor Selection by Karpoff, Stephanie, Manago, Jacqueline, Pardun, Victoria, McEntee, Nicole

“…HLA typing is key to timely donor identification, collection, and allogeneic transplant. To minimize time to donor selection and increase program efficiency,…”
Get full text

Universal posttransplant cyclophosphamide after allogeneic transplant, a retrospective single institution study by Cooper, Dennis L., Manago, Jacqueline, Patel, Vimal, Schaar, Dale, Tyno, Anne, Lin, Yong, Strair, Roger

“…The excellent results of posttransplant cyclophosphamide in decreasing graft-versus-host disease (GVHD) after haploidentical (HI) allogeneic transplant have…”
Get full text

Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation by Gorshein, Elan, Wei, Catherine, Ambrosy, Susan, Budney, Shanna, Vivas, Juliana, Shenkerman, Angelika, Manago, Jacqueline, McGrath, Mary Kate, Tyno, Anne, Lin, Yong, Patel, Vimal, Gharibo, Mecide, Schaar, Dale, Jenq, Robert R., Khiabanian, Hossein, Strair, Roger

“…Graft‐versus‐host disease (GVHD) is a major adverse effect associated with allogeneic stem cell transplant. Previous studies in mice indicated that…”
Get full text

Probiotic Enteric Regimen for Easing the Complications of Transplant by Gorshein, Elan, Ambrosy, Susan, Budney, Shanna, Vivas, Juliana, Manago, Jacqueline, McGrath, Mary Kate, Tyno, Anne, Strair, Roger

“…Probiotic Enteric Regimen for Easing the Complications of Transplant Background Since the recognition of the important role the intestinal microbiome is…”
Get full text

A Pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies by Medina, Daniel J, Gharibo, Mecide, Savage, Philip, Cohler, Alan, Kuriyan, Mercy, Balsara, Binaifer, Anand, Monika, Schaar, Dale, Krimmel, Tracy, Saggiomo, Kara, Manago, Jacqueline, Talty, Lois, Dudek, Liesel, Grospe, Stephanie, Rubin, Arnold, Strair, Roger K

“…Abstract Allogeneic hematopoietic stem cell transplantation provides curative therapy for some patients with advanced hematologic malignancies. Disease…”
Get full text

377 - Personalizing Decision Support for AML Patients by Incorporating Experienced Patient Videos About Treatment Outcomes by Fadem, Sarah, Kim, Sunyoung, Mikesell, Lisa, Aakhus, Mark, Strair, Roger, Manago, Jacqueline, McGrath, Mary Kate

Get full text

Personalizing Decision Support for AML Patients by Incorporating Experienced Patient Videos About Treatment Outcomes by Fadem, Sarah, Kim, Sunyoung, Mikesell, Lisa, Aakhus, Mark, Strair, Roger, Manago, Jacqueline, McGrath, Mary Kate

Get full text

A phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies by SCHAAR, Dale, GOODELL, Lauri, MANAGO, Jacqueline, YONG LIN, RUBIN, Eric H, CONNEY, Allan, STRAIR, Roger K, AISNER, Joseph, XIAO XING CUI, ZHENG TAO HAN, CHANG, Richard, MARTIN, John, GROSPE, Stephanie, DUDEK, Liesel, RILEY, Joan

“…Phorbol esters activate protein kinase C and modulate a variety of downstream cell signaling pathways. 12-O-tetradecanoylphorbol-13-acetate (TPA) is a phorbol…”
Get full text